Propanc Biopharma is advancing in the development of bioanalytical and immunogenicity tests for the first phase 1b study in humans for up to 50 advanced cancer patients.
Propanc Biopharma is advancing in the development of bioanalytical and immunogenicity tests for the first phase 1b study in humans for up to 50 advanced cancer patients.
Want to see every report in real time?
Hundreds of sources worldwide, translated into your language, with alerts for what matters to you.
Sign up free Already have an account? Log in